Featured

HER2-Low Expression in Breast Cancer: Opportunities for Expanding Treatment Benefit to More Patients



Published
Chair, Professor Aleix Prat, MD, PhD, Shanu Modi, MD, and Paolo Tarantino, MD, discuss breast cancer in this CME/MOC activity titled “Targeting HER2-Low Expression in Breast Cancer: Evaluating the Evidence, Challenges, and Opportunities for Expanding Treatment Benefit to More Patients.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/FGB865. CME/MOC credit will be available until October 28, 2023.
Category
Health
Be the first to comment